Recon: Pfizer begins Paxlovid trial in high-risk children; Aspen to supply own branded version of COVID vaccine in Africa
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy